Knight Therapeutics enters exclusive distribution agreement with Kyowa Kirin for Poteligeo in Latin America
Knight Therapeutics says it will seek regulatory approval and then commercialize Poteligeo (mogamulizumab) in Brazil, Mexico, Colombia and Argentina under an exclusive distribution agreement with Kyowa Kirin International.